A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency

A point mutation in the invariant GT dinucleotide splice donor site downstream of the skipped exon. The same mutation was identified in another, unrelated, Dutch patient. Because this mutation destroys a unique MaeII restriction site, rapid screening using restriction enzyme cleavage of the amplified genomic region encompassing this mutation is possible. Analysis of 50 controls revealed no individuals heterozygous for this mutation -->
ISSN: 1573-2665
0141-8955
Přístupová URL adresa: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ed951602759fe47858248000143df9
https://doi.org/10.1007/bf01799841
Rights: RESTRICTED
Přírůstkové číslo: edsair.doi.dedup.....82ed951602759fe47858248000143df9
Autor: Gerrit Smit, Henk D. Bakker, A. B. P. Van Kuilenburg, Rutger Meinsma, A. H. van Gennip, Peter Vreken, R.A. de Abreu
Přispěvatelé: Other departments
Rok vydání: 1996
Předmět:
Male
Central Nervous System
Purine-Pyrimidine Metabolism
Inborn Errors

BLOOD
LIVER
Lymphoma
Antimetabolites
Nervous System Neoplasms
Child Behavior
Cardiovascular
Polymerase Chain Reaction
5-FLUOROURACIL TOXICITY
Dihydropyrimidine dehydrogenase deficiency
Exon
Neural Tube Defects
Metabolic Processes (Non MeSH)
Hereditary Diseases
Genetics (clinical)
Netherlands
Ultrasonography
Genetics
Splice site mutation
Inborn Errors
Mental Disorders
Homozygote
Mitochondrial Myopathies
Peripheral Nervous System Diseases
JUNCTIONS
Skeletal
Exons
Neuromuscular Diseases
THYMINE-URACILURIA
Antineoplastic
Pedigree
Mitochondria
Chemistry
Restriction site
Pharmacology
Clinical

Muscle
Female
Homocystinuria
Kidney Diseases
Pediatric Oncology. Treatment of children with cancer
Oxidoreductases
Polymorphism
Restriction Fragment Length

Antimetabolites
Antineoplastic

Hypothalamo-Hypophyseal System
DNA
Complementary

RNA Splicing
Molecular Sequence Data
Pregnancy Complications
Cardiovascular

Inborn errors of metabolism
Biology
Child Nutrition Disorders
Biochemical
Clinical
Metabolic Diseases
medicine
Dihydropyrimidine dehydrogenase
Humans
Point Mutation
Clinical Trials
Genetics
Biochemical

Amino Acid Sequence
RNA
Messenger

Vascular Diseases
Kinderoncologie. Behandeling van kinderen met kanker
Erfelijke stofwisselingsziekten
Muscle
Skeletal

Vinca Alkaloids
Dihydrouracil Dehydrogenase (NADP)
DNA Primers
MONONUCLEAR-CELLS
Pharmacology
IDENTIFICATION
Base Sequence
Point mutation
DEGRADATION
Fibroblasts
medicine.disease
GENE
Myocardial Contraction
Introns
Exon skipping
Pregnancy Complications
Restriction enzyme
Metabolism
Chemistry
Clinical

Mutation
Energy Metabolism
Metabolism
Inborn Errors
Zdroj: Journal of Inherited Metabolic Disease, 19, 645-654
Journal of Inherited Metabolic Disease, 19, pp. 645-654
Journal of inherited metabolic disease, 19(5), 645-654. Springer Netherlands
Journal of Inherited Metabolic Disease, 19(5), 645-654. SPRINGER
ISSN: 1573-2665
0141-8955
Popis: Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterized by thymine-uraciluria and associated with a variable clinical phenotype. In order to identify the molecular defect underlying complete DPD deficiency in a Dutch patient previously shown to have a 165 base pair deletion in the mature DPD mRNA, we cloned the genomic region encompassing the skipped exon and its flanking intron sequences. Sequence analysis revealed that the patient was homozygous for a single G --> A point mutation in the invariant GT dinucleotide splice donor site downstream of the skipped exon. The same mutation was identified in another, unrelated, Dutch patient. Because this mutation destroys a unique MaeII restriction site, rapid screening using restriction enzyme cleavage of the amplified genomic region encompassing this mutation is possible. Analysis of 50 controls revealed no individuals heterozygous for this mutation
Databáze: OpenAIRE